AB
ABVC Biopharma Inc
🇺🇸XNAS.ABVCUnited StatesHealthcare
$1.14USDup +0.02 (+1.79%)ClosedEnd of day5:03 AM
Price$1.14+0.02 (+1.79%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US00091F3047
- CUSIP
- 00091F106
Company
- Employees
- 16
- Headquarters
- Fremont, United States
- Website
- https://www.abvcpharma.com
- CEO
- Dr. Uttam Yashwant Patil Ph.D.
Market
- Shares outstanding
- 26.7M
- Market cap
- $29.23M
Key dates
- Next earnings
- Oct 30, 2026
Highlights
- Market cap
- $29.23M
- EPS LTM
- -$0.30
- P/E LTM
- -3.76calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$7.9M-142.07%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$2.69M-53.25%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.